Back
Janux Therapeutics Vs. BridgeBio Pharma Industry Stock Comparison
Sell
34
JANX
Janux Therapeutics
Last Price:
50.03
Seasonality Move:
-11.26%
Sell
39
BBIO
BridgeBio Pharma
Last Price:
26.81
Seasonality Move:
21.04%
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy, Sell or Hold?
- The current Janux Therapeutics [JANX] share price is $48.32. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- JANX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
BridgeBio Pharma (BBIO)
is a Sell
Is BridgeBio Pharma a Buy, Sell or Hold?
- The current BridgeBio Pharma [BBIO] share price is $25.96. The Score for BBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- BBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JANX Stock Price Chart
What is Janux Therapeutics's stock price today?
-
The Janux Therapeutics share price today is $48.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.
BBIO Stock Price Chart
What is BridgeBio Pharma's stock price today?
-
The BridgeBio Pharma share price today is $25.96
The current trend is relatively stagnant and BBIO is experiencing selling pressure, which indicates risk of future bearish movement.
JANX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.66 | Buy |
Relative Strength Index (14 RSI): | 58.88 | Buy |
Chaikin Money Flow: | -477293 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (42.34 - 47.54) | Buy |
Bollinger Bands (100): | (39.32 - 50.86) | Buy |
BBIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 44.56 | Sell |
Chaikin Money Flow: | -1012647 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.61 - 29.05) | Sell |
Bollinger Bands (100): | (25.05 - 28.77) | Sell |
JANX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 46.9 | Buy |
20-day SMA: | 45.61 | Buy |
50-day SMA: | 43.17 | Buy |
200-day SMA: | 34.43 | Buy |
8-day EMA: | 47.48 | Buy |
20-day EMA: | 45.59 | Buy |
50-day EMA: | 43.99 | Buy |
200-day EMA: | 36.11 | Buy |
BBIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.59 | Sell |
20-day SMA: | 27.31 | Sell |
50-day SMA: | 26.49 | Sell |
200-day SMA: | 30.04 | Sell |
8-day EMA: | 27.11 | Sell |
20-day EMA: | 27.18 | Sell |
50-day EMA: | 26.81 | Sell |
200-day EMA: | 27.48 | Sell |
Janux Therapeutics Earnings Growth & JANX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.19 per share, and a decrease next year of $0.46 per share.
BridgeBio Pharma Earnings Growth & BBIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.01 per share, an increase this year of $1.24 per share, and a decrease next year of $1.28 per share.
Janux Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
BridgeBio Pharma Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |